Citadel Advisors
ALHC icon

Citadel Advisors’s Alignment Healthcare ALHC Stock Holding History

Citadel Advisors’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.5M Buy
5,362,666
+1,021,800
+24% +$20.5M 0.02% 845
2025
Q4 		$85.7M Sell
4,340,866
-1,824,341
-30% -$32.8M 0.01% 958
2025
Q3 		$108M Sell
6,165,207
-2,158,673
-26% -$32M 0.02% 795
2025
Q2 		$117M Buy
8,323,880
+8,079,612
+3,308% +$130M 0.02% 675
2025
Q1 		$4.55M Sell
244,268
-2,844,497
-92% -$42.4M ﹤0.01% 4027
2024
Q4 		$34.7M Buy
+3,088,765
New +$36.1M 0.01% 1604
2024
Q3 		– Sell
-1,257,276
Closed -$9.83M – 14158
2024
Q2 		$9.83M Sell
1,257,276
-375,191
-23% -$2.45M ﹤0.01% 2797
2024
Q1 		$8.1M Sell
1,632,467
-25,079
-2% -$161K ﹤0.01% 3218
2023
Q4 		$14.3M Buy
1,657,546
+1,079,190
+187% +$7.89M ﹤0.01% 2390
2023
Q3 		$4.01M Buy
578,356
+413,789
+251% +$2.5M ﹤0.01% 4003
2023
Q2 		$946K Buy
+164,567
New +$1.06M ﹤0.01% 6577
2023
Q1 		– Sell
-163,371
Closed -$1.92M – 14655
2022
Q4 		$1.92M Sell
163,371
-1,062,101
-87% -$12.9M ﹤0.01% 5560
2022
Q3 		$14.5M Buy
1,225,472
+727,930
+146% +$10.6M ﹤0.01% 2261
2022
Q2 		$5.68M Sell
497,542
-93,743
-16% -$989K ﹤0.01% 3559
2022
Q1 		$6.64M Sell
591,285
-203,437
-26% -$1.83M ﹤0.01% 3635
2021
Q4 		$11.2M Buy
794,722
+678,311
+583% +$11.9M ﹤0.01% 2891
2021
Q3 		$1.86M Buy
116,411
+10,360
+10% +$200K ﹤0.01% 6551
2021
Q2 		$2.48M Buy
+106,051
New +$2.58M ﹤0.01% 6069

Other funds holding ALHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Citadel Advisors's ALHC Position: Q1 2026 in Review

Citadel Advisors increased its Alignment Healthcare (ALHC) stake by 24% in Q1 2026, buying an estimated $20.5M and bringing the position to 5,362,666 shares worth $94.5M. The position accounts for 0.02% of the portfolio, ranked #845.

Citadel Advisors first reported a position in ALHC in Q2 2021 and has held it in 18 quarters since. The position peaked at $117M in Q2 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Citadel Advisors held 5,362,666 shares of Alignment Healthcare worth $94.5M as of Q1 2026.
  • Citadel Advisors bought 1,021,800 Alignment Healthcare shares in Q1 2026, an estimated $20.5M.
  • Alignment Healthcare made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #845 holding.
  • Citadel Advisors first reported a position in Alignment Healthcare in Q2 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Alignment Healthcare position peaked at $117M in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.